HEADER TRANSCRIPTION 17-OCT-12 4HLW TITLE TARGETING THE BINDING FUNCTION 3 (BF3) SITE OF THE HUMAN ANDROGEN TITLE 2 RECEPTOR THROUGH VIRTUAL SCREENING. 2. DEVELOPMENT OF 2-((2- TITLE 3 PHENOXYETHYL) THIO)-1H-BENZOIMIDAZOLE DERIVATIVES. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANDROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 664-919; COMPND 5 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP C MEMBER 4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AR, DHTR, NR3C4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS NUCLEAR HORMONE RECEPTOR, ANDROGEN BINDING DOMAIN, TRANSCRIPTIONAL KEYWDS 2 FACTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.N.M.RAVI,E.LEBLANC,P.AXERIO-CILIES,C.LABRIERE,K.FREWIN, AUTHOR 2 M.D.H.HASSONA,N.A.LACK,F.Q.HAN,E.S.GUNS,R.YOUNG,F.BAN,P.S.RENNIE, AUTHOR 3 A.CHERKASOV REVDAT 2 27-FEB-13 4HLW 1 JRNL REVDAT 1 23-JAN-13 4HLW 0 JRNL AUTH R.S.MUNUGANTI,E.LEBLANC,P.AXERIO-CILIES,C.LABRIERE,K.FREWIN, JRNL AUTH 2 K.SINGH,M.D.HASSONA,N.A.LACK,H.LI,F.BAN,E.TOMLINSON GUNS, JRNL AUTH 3 R.YOUNG,P.S.RENNIE,A.CHERKASOV JRNL TITL TARGETING THE BINDING FUNCTION 3 (BF3) SITE OF THE ANDROGEN JRNL TITL 2 RECEPTOR THROUGH VIRTUAL SCREENING. 2. DEVELOPMENT OF JRNL TITL 3 2-((2-PHENOXYETHYL) THIO)-1H-BENZIMIDAZOLE DERIVATIVES. JRNL REF J.MED.CHEM. V. 56 1136 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23301637 JRNL DOI 10.1021/JM3015712 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 9705 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 466 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.4231 - 3.6052 1.00 3194 154 0.1494 0.2001 REMARK 3 2 3.6052 - 2.8617 1.00 3037 161 0.1999 0.2906 REMARK 3 3 2.8617 - 2.5000 1.00 3008 151 0.2373 0.3003 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.010 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2057 REMARK 3 ANGLE : 1.203 2793 REMARK 3 CHIRALITY : 0.076 310 REMARK 3 PLANARITY : 0.005 348 REMARK 3 DIHEDRAL : 14.832 743 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: all REMARK 3 ORIGIN FOR THE GROUP (A): 21.4180 4.9054 11.4271 REMARK 3 T TENSOR REMARK 3 T11: 0.2150 T22: 0.2458 REMARK 3 T33: 0.2338 T12: -0.0648 REMARK 3 T13: -0.0656 T23: 0.0372 REMARK 3 L TENSOR REMARK 3 L11: 1.3395 L22: 2.3020 REMARK 3 L33: 2.4443 L12: 0.2758 REMARK 3 L13: -0.6923 L23: -0.0785 REMARK 3 S TENSOR REMARK 3 S11: -0.0521 S12: 0.1628 S13: 0.0421 REMARK 3 S21: -0.1082 S22: 0.0800 S23: -0.0198 REMARK 3 S31: 0.1066 S32: -0.1644 S33: -0.0217 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HLW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-12. REMARK 100 THE RCSB ID CODE IS RCSB075629. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9705 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 42.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.35MNA2HPO4/K2HPO4, 0.1M (NH4)2HPO4, REMARK 280 7.0% POLYETHYLENE GLYCOL 400 (PEG 400), AND 50MM TRIS-HCL AT PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.59500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.50500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.50500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.59500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 664 REMARK 465 GLU A 665 REMARK 465 GLY A 666 REMARK 465 TYR A 667 REMARK 465 GLU A 668 REMARK 465 CYS A 669 REMARK 465 CYS A 844 REMARK 465 LYS A 845 REMARK 465 ARG A 846 REMARK 465 LYS A 847 REMARK 465 ASN A 848 REMARK 465 PRO A 849 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 670 CG CD OE1 NE2 REMARK 470 GLU A 678 CG CD OE1 OE2 REMARK 470 GLN A 693 CG CD OE1 NE2 REMARK 470 ARG A 760 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 819 CG OD1 OD2 REMARK 470 LYS A 825 CG CD CE NZ REMARK 470 GLU A 829 CG CD OE1 OE2 REMARK 470 LYS A 836 CG CD CE NZ REMARK 470 ARG A 854 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 893 CG CD OE1 OE2 REMARK 470 LYS A 912 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 890 CG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 759 8.82 54.96 REMARK 500 LEU A 768 75.66 -159.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TES A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 17W A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1004 DBREF 4HLW A 664 919 UNP P10275 ANDR_HUMAN 664 919 SEQRES 1 A 256 ILE GLU GLY TYR GLU CYS GLN PRO ILE PHE LEU ASN VAL SEQRES 2 A 256 LEU GLU ALA ILE GLU PRO GLY VAL VAL CYS ALA GLY HIS SEQRES 3 A 256 ASP ASN ASN GLN PRO ASP SER PHE ALA ALA LEU LEU SER SEQRES 4 A 256 SER LEU ASN GLU LEU GLY GLU ARG GLN LEU VAL HIS VAL SEQRES 5 A 256 VAL LYS TRP ALA LYS ALA LEU PRO GLY PHE ARG ASN LEU SEQRES 6 A 256 HIS VAL ASP ASP GLN MET ALA VAL ILE GLN TYR SER TRP SEQRES 7 A 256 MET GLY LEU MET VAL PHE ALA MET GLY TRP ARG SER PHE SEQRES 8 A 256 THR ASN VAL ASN SER ARG MET LEU TYR PHE ALA PRO ASP SEQRES 9 A 256 LEU VAL PHE ASN GLU TYR ARG MET HIS LYS SER ARG MET SEQRES 10 A 256 TYR SER GLN CYS VAL ARG MET ARG HIS LEU SER GLN GLU SEQRES 11 A 256 PHE GLY TRP LEU GLN ILE THR PRO GLN GLU PHE LEU CYS SEQRES 12 A 256 MET LYS ALA LEU LEU LEU PHE SER ILE ILE PRO VAL ASP SEQRES 13 A 256 GLY LEU LYS ASN GLN LYS PHE PHE ASP GLU LEU ARG MET SEQRES 14 A 256 ASN TYR ILE LYS GLU LEU ASP ARG ILE ILE ALA CYS LYS SEQRES 15 A 256 ARG LYS ASN PRO THR SER CYS SER ARG ARG PHE TYR GLN SEQRES 16 A 256 LEU THR LYS LEU LEU ASP SER VAL GLN PRO ILE ALA ARG SEQRES 17 A 256 GLU LEU HIS GLN PHE THR PHE ASP LEU LEU ILE LYS SER SEQRES 18 A 256 HIS MET VAL SER VAL ASP PHE PRO GLU MET MET ALA GLU SEQRES 19 A 256 ILE ILE SER VAL GLN VAL PRO LYS ILE LEU SER GLY LYS SEQRES 20 A 256 VAL LYS PRO ILE TYR PHE HIS THR GLN HET TES A1001 21 HET 17W A1002 19 HET GOL A1003 6 HET SO4 A1004 5 HETNAM TES TESTOSTERONE HETNAM 17W 2-[(2-PHENOXYETHYL)SULFANYL]-1H-BENZIMIDAZOLE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 TES C19 H28 O2 FORMUL 3 17W C15 H14 N2 O S FORMUL 4 GOL C3 H8 O3 FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *8(H2 O) HELIX 1 1 PRO A 671 GLU A 681 1 11 HELIX 2 2 SER A 696 ALA A 721 1 26 HELIX 3 3 GLY A 724 LEU A 728 5 5 HELIX 4 4 HIS A 729 VAL A 757 1 29 HELIX 5 5 ASN A 771 SER A 778 1 8 HELIX 6 6 MET A 780 GLN A 798 1 19 HELIX 7 7 THR A 800 LEU A 812 1 13 HELIX 8 8 ASN A 823 ALA A 843 1 21 HELIX 9 9 SER A 851 SER A 865 1 15 HELIX 10 10 SER A 865 LYS A 883 1 19 HELIX 11 11 PRO A 892 GLN A 902 1 11 HELIX 12 12 GLN A 902 SER A 908 1 7 SHEET 1 A 2 LEU A 762 ALA A 765 0 SHEET 2 A 2 LEU A 768 PHE A 770 -1 O PHE A 770 N LEU A 762 SHEET 1 B 2 ILE A 815 PRO A 817 0 SHEET 2 B 2 VAL A 911 PRO A 913 -1 O LYS A 912 N ILE A 816 SITE 1 AC1 5 LEU A 704 ASN A 705 GLN A 711 ARG A 752 SITE 2 AC1 5 THR A 877 SITE 1 AC2 7 PHE A 673 PRO A 723 ASN A 727 LEU A 830 SITE 2 AC2 7 GLU A 837 ARG A 840 ILE A 882 SITE 1 AC3 4 PRO A 682 GLN A 711 VAL A 715 LYS A 808 SITE 1 AC4 5 SER A 696 PHE A 697 LYS A 777 ARG A 779 SITE 2 AC4 5 SER A 853 CRYST1 55.190 66.300 73.010 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018119 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015083 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013697 0.00000 MASTER 288 0 4 12 4 0 7 6 0 0 0 20 END